Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee Osteoarthritis
Clinical trial NCT00643799 · COMPLETED
Trial details
- NCT number
- NCT00643799
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2005-01-01
- Enrollment
- 586
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.